Sangamo Therapeutics SGMOQ
OTC SGMOQ
$0.11 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Sangamo Therapeutics (SGMOQ) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Sangamo Therapeutics' Return on Capital Employed [ROCE] came in at -1838.37% for Q1 2026, down 1653.27 percentage points from -185.10% a year earlier and down 1456.25 percentage points from the prior quarter.

Analysis

Sangamo Therapeutics (SGMOQ) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Sangamo Therapeutics' Return on Capital Employed [ROCE] was -317.18%, down 198.59 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined in each of the last six years, with a five-year change of -297.08 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -118.59% in FY2024 (-31.93 pp), -86.66% in FY2023 (-48.72 pp), -37.94% in FY2022 (-11.84 pp) and -26.10% in FY2021 (-6.00 pp).
  • The Q1 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for three consecutive quarters, with an average year-over-year change of -240.09 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2025 (a gain of 214.97 percentage points), and the weakest in Q1 2026 (a drop of 1653.27 percentage points).
  • Business Quant data shows SGMOQ's Return on Capital Employed [ROCE] at -382.12% (Q4 2025), -253.69% (Q3 2025) and -142.17% (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Sangamo Therapeutics 45.57 Mn -70.94 Mn - -1,838.37%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,838.37%
Dec 31, 2025 -382.12%
Sep 30, 2025 -253.69%
Jun 30, 2025 -142.17%
Mar 31, 2025 -185.10%
Dec 31, 2024 -171.44%
Sep 30, 2024 -237.44%
Jun 30, 2024 -357.14%
Mar 31, 2024 -321.39%
Dec 31, 2023 -189.26%
Sep 30, 2023 -119.40%
Jun 30, 2023 -65.59%
Mar 31, 2023 -31.10%
Dec 31, 2022 -43.15%
Sep 30, 2022 -38.45%
Jun 30, 2022 -34.77%
Mar 31, 2022 -32.00%
Dec 31, 2021 -29.61%
Sep 30, 2021 -27.81%
Jun 30, 2021 -19.76%
API Access

Sangamo Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY